Cargando…
Propofol-Related Infusion Syndrome in the Peripartum Period
Background Propofol is a widely known, commonly used drug. Complications can occur with the use of this drug, including propofol-related infusion syndrome (PRIS). PRIS, in the obstetric population, has not been documented; however, we report a case of a patient who developed PRIS after an emergent c...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical Publishers
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061574/ https://www.ncbi.nlm.nih.gov/pubmed/27738550 http://dx.doi.org/10.1055/s-0036-1593405 |
_version_ | 1782459622871793664 |
---|---|
author | Eziefule, Akwugo A. Elshatanoufy, Solafa Thakur, Mili Rocha, Frederico G. |
author_facet | Eziefule, Akwugo A. Elshatanoufy, Solafa Thakur, Mili Rocha, Frederico G. |
author_sort | Eziefule, Akwugo A. |
collection | PubMed |
description | Background Propofol is a widely known, commonly used drug. Complications can occur with the use of this drug, including propofol-related infusion syndrome (PRIS). PRIS, in the obstetric population, has not been documented; however, we report a case of a patient who developed PRIS after an emergent cesarean delivery of a preterm infant. Case Study A 35-year-old multigravida woman presented complaining of leakage of fluid and decreased fetal movement. Her pregnancy was complicated by methadone maintenance therapy due to a history of opioid abuse. Complications after admission for prolonged monitoring and a prolonged fetal heart tone deceleration was noted with no recovery despite intrauterine resuscitation. An emergent cesarean delivery was performed using general anesthesia and endotracheal intubation after which she developed aspiration pneumonia. She was admitted to the intensive care unit and reintubation and sedation were required secondary to respiratory distress. Sedation was achieved using propofol infusion. She subsequently developed changes in her electrocardiogram, an increase of her serum creatinine, creatinine protein kinase, lipase, amylase, and triglycerides, making the diagnosis of PRIS. Conclusion PRIS should be included in the differential diagnosis of intubated or postoperative patients in the obstetric population. |
format | Online Article Text |
id | pubmed-5061574 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Thieme Medical Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-50615742016-10-13 Propofol-Related Infusion Syndrome in the Peripartum Period Eziefule, Akwugo A. Elshatanoufy, Solafa Thakur, Mili Rocha, Frederico G. AJP Rep Background Propofol is a widely known, commonly used drug. Complications can occur with the use of this drug, including propofol-related infusion syndrome (PRIS). PRIS, in the obstetric population, has not been documented; however, we report a case of a patient who developed PRIS after an emergent cesarean delivery of a preterm infant. Case Study A 35-year-old multigravida woman presented complaining of leakage of fluid and decreased fetal movement. Her pregnancy was complicated by methadone maintenance therapy due to a history of opioid abuse. Complications after admission for prolonged monitoring and a prolonged fetal heart tone deceleration was noted with no recovery despite intrauterine resuscitation. An emergent cesarean delivery was performed using general anesthesia and endotracheal intubation after which she developed aspiration pneumonia. She was admitted to the intensive care unit and reintubation and sedation were required secondary to respiratory distress. Sedation was achieved using propofol infusion. She subsequently developed changes in her electrocardiogram, an increase of her serum creatinine, creatinine protein kinase, lipase, amylase, and triglycerides, making the diagnosis of PRIS. Conclusion PRIS should be included in the differential diagnosis of intubated or postoperative patients in the obstetric population. Thieme Medical Publishers 2016-10 /pmc/articles/PMC5061574/ /pubmed/27738550 http://dx.doi.org/10.1055/s-0036-1593405 Text en © Thieme Medical Publishers |
spellingShingle | Eziefule, Akwugo A. Elshatanoufy, Solafa Thakur, Mili Rocha, Frederico G. Propofol-Related Infusion Syndrome in the Peripartum Period |
title | Propofol-Related Infusion Syndrome in the Peripartum Period |
title_full | Propofol-Related Infusion Syndrome in the Peripartum Period |
title_fullStr | Propofol-Related Infusion Syndrome in the Peripartum Period |
title_full_unstemmed | Propofol-Related Infusion Syndrome in the Peripartum Period |
title_short | Propofol-Related Infusion Syndrome in the Peripartum Period |
title_sort | propofol-related infusion syndrome in the peripartum period |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061574/ https://www.ncbi.nlm.nih.gov/pubmed/27738550 http://dx.doi.org/10.1055/s-0036-1593405 |
work_keys_str_mv | AT eziefuleakwugoa propofolrelatedinfusionsyndromeintheperipartumperiod AT elshatanoufysolafa propofolrelatedinfusionsyndromeintheperipartumperiod AT thakurmili propofolrelatedinfusionsyndromeintheperipartumperiod AT rochafredericog propofolrelatedinfusionsyndromeintheperipartumperiod |